Improving HIV care engagement for cancer patients in Zimbabwe
Development and Evaluation of a Multi-Component Intervention to Support HIV Care Engagement Among Patients Receiving Cancer Treatment in Zimbabwe
This study is trying to find ways to help people in Zimbabwe who have both HIV and cancer get better access to their HIV care while they are being treated for cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Fred Hutchinson Cancer Center Academic / other |
| Locations | 1 site (Harare) |
| Trial ID | NCT06934369 on ClinicalTrials.gov |
What this trial studies
This project aims to enhance the engagement of HIV-positive individuals undergoing cancer treatment in Zimbabwe. It focuses on identifying barriers that hinder access to HIV care while patients are receiving cancer treatment. The study will observe 150 patients at Parirenyatwa Hospital in Harare, measuring disruptions in HIV care engagement and developing strategies to address these challenges. By collaborating with experts and stakeholders, the project seeks to create effective interventions to improve care continuity for these patients.
Who should consider this trial
Good fit: Ideal candidates for this study are HIV-positive individuals aged 18 or older who are receiving cancer treatment for a new diagnosis at Parirenyatwa Hospital.
Not a fit: Patients with benign diagnoses or those experiencing cancer recurrence may not benefit from this study.
Why it matters
Potential benefit: If successful, this initiative could significantly improve the health outcomes of patients with both HIV and cancer by ensuring they remain engaged in their HIV treatment during cancer therapy.
How similar studies have performed: While the approach of integrating HIV and cancer care is critical, this specific study's methodology is novel and has not been extensively tested in similar contexts.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 or older * Registered patient at Parirenyatwa Hospital Radiotherapy Centre, receiving cancer treatment for a new diagnosis * HIV-positive Exclusion Criteria: * Benign diagnosis or cancer recurrence
Where this trial is running
Harare
- Parirenyatwa Hospital — Harare, Zimbabwe (Recruiting)
Study contacts
- Principal investigator: Michalina Montaño, PhD — Fred Hutchinson Cancer Center
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.